Psoriatic Arthritis Treatment Market: Key Drivers, Trends, Growth, Outlook, and Forecast 2024-2033

The Psoriatic Arthritis Treatment Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Psoriatic Arthritis Treatment Market:

https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

According to The Business Research Company’s Psoriatic Arthritis Treatment Global Market Report 2024, The psoriatic arthritis treatment market size has grown strongly in recent years. It will grow from $10.93 billion in 2023 to $12 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%.  The  growth in the historic period can be attributed to increased diagnosis, rising prevalence of psoriatic arthritis, increasing awareness of psoriatic arthritis and its treatments, expanding range of approved psoriatic arthritis treatments, government support for research and development, increased investment from pharmaceutical companies.

The psoriatic arthritis treatment market size is expected to see strongly grown in the next few years. It will grow to $17.16 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%.  The growth in the forecast period can be attributed to personalized medicine, emerging biologics and small molecules, expanding treatment options, global aging population. Major trends in the forecast period include advancements in biologics, oral small molecules, targeting specific pathways, telemedicine and remote monitoring, patient-centered care, real-world evidence.

The rise in the prevalence of psoriasis and psoriatic arthritis boosted the growth of the psoriatic arthritis treatment market. Psoriasis (PSO) and psoriatic arthritis (PsA) are inflammatory disorders that can severely impair health and quality of life. Psoriasis is associated with inflammatory arthritis, known as psoriatic arthritis (PsA), with an incidence of 30% in psoriatic patients. For instance, in June 2021, according to the National Psoriasis Foundation, a US-based healthcare agency, more than 8 million people in the United States and 125 million people worldwide suffered from psoriasis, a chronic immune-mediated illness. Furthermore, in the USA, about 30% of people with psoriasis also develop psoriatic arthritis. Thus, an increase in the prevalence of psoriasis and psoriatic arthritis drives market growth.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp

The psoriatic arthritis treatment market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Technological advancements are an emerging trend in the rapid microbiology testing kits market. This is mainly because these technological advancements improve the reliability and efficiency of tests and testing methods. Automation in rapid microbial detection enables higher throughputs and greater accuracy in results. Similarly, robotic cassette handling, incubation, and imaging reduce the risks of miscounts, mid-test contamination, and incorrect data entry, which leads to fewer false positives and out-of-specification investigations. Fewer investigations then ultimately improve uptime and reduce delay and recall of tests. For example, Abbott Laboratories announced the next generation Alinity HQ Haematology Analyzer that is aimed to minimize errors and reduce manual steps in testing.

The psoriatic arthritis treatment market report table of contents includes:

  1. Executive Summary
  2. Psoriatic Arthritis Treatment Market Characteristics
  3. Psoriatic Arthritis Treatment Market Trends And Strategies
  4. Psoriatic Arthritis Treatment Market – Macro Economic Scenario
  5. Global Psoriatic Arthritis Treatment Market Size and Growth

.

.

.

  1. Global Psoriatic Arthritis Treatment Market Competitive Benchmarking
  2. Global Psoriatic Arthritis Treatment Market Competitive Dashboard
  3. Key Mergers And Acquisitions In The Psoriatic Arthritis Treatment Market
  4. Psoriatic Arthritis Treatment Market Future Outlook and Potential Analysis
  5. Appendix

Top 5 Major Key Players Are:

  • AbbVie Inc
  • Amgen Astellas BioPharma K.K
  • Johnson & Johnson Services Inc
  • Bristol-Myers Squibb Company
  • Celgene Corporation

Related Reports:

https://goodprnews.com/charge-card-market/

https://goodprnews.com/checkpoint-inhibitors-market/

https://goodprnews.com/clean-label-ingredients-market/

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model